Parenting tech company Ovuline rebrands as Ovia

Women’s healthcare technology company Ovuline is rebranding itself as Ovia Health after receiving $10 million in funding.

Ovia, based in Boston, specializes in fertility, pregnancy and parenting apps. It has more than five million users and reports to have influenced about 40 percent of U.S. births, the company said in a statement.

"We changed our name to Ovia Health to reflect our broader commitment to women's and family health and our expertise in driving the innovations needed to shape the future of healthcare," said Paris Wallace, CEO and president of Ovia, in a statement. "The name is also inspired by the millions who've trusted the Ovia apps with the health of their families."

Ovia also works with employers and helps them recruit and retain employees with children.

The new funding will help them expand their maternity benefits to employers and insurers across the country, including Blue Cross Blue Shield of Massachusetts, Activision Blizzard, Optum and General Electric.

"The new funding recognizes the immense impact we are making on so many women and families," said founder and CTO Alex Baron. "Our users are delighted by our products, and employers and health insurers value our secure platform and data-driven approach. We're creating a new kind of family healthcare."

Katherine Davis,

Senior Writer

As a Senior Writer for TriMed Media Group, Katherine primarily focuses on producing news stories, Q&As and features for Cardiovascular Business. She reports on several facets of the cardiology industry, including emerging technology, new clinical trials and findings, and quality initiatives among providers. She is based out of TriMed's Chicago office and holds a bachelor's degree in journalism from Columbia College Chicago. Her work has appeared in Modern Healthcare, Crain's Chicago Business and The Detroit News. She joined TriMed in 2016.

Around the web

Compensation for heart specialists continues to climb. What does this say about cardiology as a whole? Could private equity's rising influence bring about change? We spoke to MedAxiom CEO Jerry Blackwell, MD, MBA, a veteran cardiologist himself, to learn more.

The American College of Cardiology has shared its perspective on new CMS payment policies, highlighting revenue concerns while providing key details for cardiologists and other cardiology professionals. 

As debate simmers over how best to regulate AI, experts continue to offer guidance on where to start, how to proceed and what to emphasize. A new resource models its recommendations on what its authors call the “SETO Loop.”